<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25193">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02083614</url>
  </required_header>
  <id_info>
    <org_study_id>CIUCGY-1</org_study_id>
    <nct_id>NCT02083614</nct_id>
  </id_info>
  <brief_title>The Effect of Clamping the Indwelling Urethral Catheter Before Removal From Patients After Type III Radical Hysterectomy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital of Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital of Chongqing Medical University</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of clamping the indwelling urethral catheter before removal is an unsettled issue
      in clinical practice. No studies have done before in the patients with gynecologic cancers
      who received radical hysterectomy. We hypothesized that clamping the catheter would decrease
      the rate of recatheterization. In addition, the feeling of urination during clamping is
      correlated with lower rate of  recatheterization after removal.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care</study_design>
  <primary_outcome>
    <measure>rate of recatheterization</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>clamping</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>to clamp or release the catheter for 2 days before removal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>no clamping</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>to clamp or release the catheter for 2 days before removal</intervention_name>
    <arm_group_label>clamping</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients receiving Piver III radical hysterectomy

          -  catheterization over 7 days

        Exclusion Criteria:

          -  catheterization shorter than 7 days
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>fulan wang</last_name>
    <phone>00862389011080</phone>
    <email>wfl3076@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ling zhao</last_name>
    <phone>00862389011006</phone>
    <email>239648507@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fulan Wang</name>
      <address>
        <city>Chongqing</city>
        <zip>400016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>ling zhao</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 8, 2014</lastchanged_date>
  <firstreceived_date>March 8, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital of Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Yao Gong</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
